Analyst Ratings for Synergy Pharmaceuticals (SGYP) [Buys]
SGYP Rating Summary
SGYP Price Target Summary
- Highest: $25.00 (Aegis Capital)
- Lowest: $9.00 (Summer Street)
- Average: $14.40
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$14.40 (+181.8%)
Avg. $ Target:
$14.40 (+181.8%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/25/2012 | Cantor Fitzgerald » Updated 1/2/2013 |
New Coverage | Buy (N/A) |
13.00 (7.00) |
4.71 | 5.11 | 8.49% | Details |
| 6/12/2012 | Aegis Capital | New Coverage | Buy (N/A) |
25.00 (N/A) |
4.66 | 5.11 | 9.66% | Details |
| 4/5/2012 | Roth Capital | New Coverage | Buy (N/A) |
12.00 (N/A) |
4.00 | 5.11 | 27.75% | Details |
| 3/29/2012 | Brean Capital | New Coverage | Buy (N/A) |
13.00 (N/A) |
3.99 | 5.11 | 28.07% | Details |
| 3/22/2012 | Summer Street | New Coverage | Buy (N/A) |
9.00 (N/A) |
4.15 | 5.11 | 23.13% | Details |
| 5/13/2011 | Morgan Joseph | New Coverage | Buy (N/A) |
N/A (N/A) |
3.03 | 5.11 | 68.65% | Details |
| 10/13/2010 | Global Hunter Securities | New Coverage | Buy (N/A) |
N/A (N/A) |
4.95 | 5.11 | 3.23% | Details |
